摘要
目的:观察中西医结合治疗蛛网膜下腔出血的临床疗效。方法:将符合纳入标准的208例本病患者随机分为对照组和治疗组,每组104例,对照组予以常规治疗和尼莫地平持续微量泵输注防治蛛网膜下腔出血,治疗组在对照组的基础上按照分型予中医治疗,观察两组患者临床疗效。结果:治疗组4种分型治疗有效率分别为88.9%、85.7%、90.0%和85%;对照组4种分型治疗有效率分别为55.5%、42.9%、50.0%和62.5%,两组比较,差异有统计学意义(P<0.05);治疗组症状改善优于对照组(P<0.05)。结论:中西医结合治疗蛛网膜下腔出血效果显著,可以减少患者并发症的发生,提高临床疗效。
Objective： To observe the clinical effect of integrated Chinese-western therapy on subarachnoid hemorrhage. Methods： The 208 cases were randomly divided into control group and treatment group, 104 cases in each. The control group was treated with conventional treatment and Nimodipine sustained micro infusion pump to prevent subarachnoid hemorrhage. The treatment group was given TCM based on the control group. Then the clinical efficacy was observed after the treatment. Results： The effective rate of the 4 types in the treatment group was respectively 88.9%, 85.7%, 90% and 85%, while the control group was 55.5%, 42.9%, 50% and 62.5%. The results have significant difference between the 2 groups（P〈0.05）, the improving of treatment group was better than control group（P〈0.05）.The Chinese and Western medicine is effective with subarachnoid hemorrhage, can reduce the complications and improve the clinical efficacy.
出处
《中医药导报》
2014年第12期74-76,共3页
Guiding Journal of Traditional Chinese Medicine and Pharmacy
关键词
蛛网膜下腔出血
中西医结合
辨证分型
Subarachnoid Hemorrhage
Integrated Chinese-western Therapy
Syndrome Differentiation
